Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

GNANAGURDASAN PRAKASAM

Allopathic & Osteopathic Physicians Pediatrics Pediatric Endocrinology

NPI
1871586065
CMS profile
176290
Location
SACRAMENTO, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2021 · Entire year

$92,637.89

208 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2021 · entire year · sorted by reported total

By paying entity

PY2021 · entire year · sorted by reported total

Page 4 of 5; records 151–200 of 208 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

GNANAGURDASAN PRAKASAM

NPI 1871586065 · CMS profile ID 176290

Allopathic & Osteopathic Physicians / Pediatrics / Pediatric Endocrinology

SACRAMENTO, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 4 of 5; records 151–200 of 208 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1871586065?year=2021&recipient=provider&page=4#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
GNANAGURDASAN PRAKASAM, NPI 1871586065, CMS profile ID 176290. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 4 of 5; records 151–200 of 208 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1871586065?year=2021&recipient=provider&page=4#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
APA 7
IndustryPayments. (2026). GNANAGURDASAN PRAKASAM, NPI 1871586065, CMS profile ID 176290. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 4 of 5; records 151–200 of 208 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1871586065?year=2021&recipient=provider&page=4#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
Bluebook
GNANAGURDASAN PRAKASAM, NPI 1871586065, CMS profile ID 176290, IndustryPayments, General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 4 of 5; records 151–200 of 208 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202. https://industrypayments.org/provider/npi-1871586065?year=2021&recipient=provider&page=4#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2021 · Physicians and non-physician practitioners · CMS publication 2026-06-30

208 matching records · $92,637.89 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 208 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 151–200 of 208.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
AbbVie Inc. $23.4604/15/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 795695823 CMS
AbbVie Inc. $4.5504/15/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 795695829 CMS
VistaPharm, Inc. $21.9104/14/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 837695099 CMS
Alexion Pharmaceuticals, Inc. $620.0004/13/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783122629 CMS
Novo Nordisk Inc $1,700.0004/09/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 810839155 CMS
Novo Nordisk Inc $23.6904/09/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 811223191 CMS
Novo Nordisk Inc $50.0004/09/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 811647441 CMS
Novo Nordisk Inc $7.0804/07/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 811223185 CMS
Novo Nordisk Inc $794.7504/05/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 811647437 CMS
Lilly USA, LLC $19.2304/04/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 819079215 CMS
Lilly USA, LLC $400.0004/02/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 819174039 CMS
Becton, Dickinson and Company $14.9703/30/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 836110949 CMS
AbbVie Inc. $4.6903/29/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 795695817 CMS
LifeScan, Inc. $17.1403/24/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 845331991 CMS
Lilly USA, LLC $800.0003/24/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 819151525 CMS
Medtronic, Inc. $16.5203/24/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 815703411 CMS
Lilly USA, LLC $1,600.0003/23/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 819151529 CMS
Tandem Diabetes Care, Inc. $20.7403/18/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 854165633 CMS
Lilly USA, LLC $800.0003/17/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 819174035 CMS
Novo Nordisk Inc $9.0003/16/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 810693543 CMS
AbbVie Inc. $15.6203/12/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 795695811 CMS
Lilly USA, LLC $800.0003/12/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 819108779 CMS
AbbVie Inc. $1.0003/11/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 795695799 CMS
AbbVie Inc. $3.2303/11/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 795695805 CMS
AbbVie Inc. $1,350.0003/09/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 795695793 CMS
Lilly USA, LLC $800.0003/09/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 819079211 CMS
Medtronic, Inc. $18.7903/04/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 815597825 CMS
AbbVie Inc. $18.6403/03/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 795695787 CMS
Novo Nordisk Inc $8.3803/03/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 810839149 CMS
Ultragenyx Pharmaceutical Inc. $2,100.0003/03/2021 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848976277 CMS
VistaPharm, Inc. $22.7203/03/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 837695097 CMS
AbbVie Inc. $4.5003/02/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 795695781 CMS
Lilly USA, LLC $22.4103/01/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 819096873 CMS
Ultragenyx Pharmaceutical Inc. $1,050.0002/26/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848976251 CMS
AbbVie Inc. $1,350.0002/24/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 795695775 CMS
AbbVie Inc. $1,350.0002/19/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 795695769 CMS
Novo Nordisk Inc $4.8202/19/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 811733031 CMS
BioMarin Pharmaceutical Inc. $38.0002/17/2021 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 831398993 CMS
BioMarin Pharmaceutical Inc. $330.0002/17/2021 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 831398995 CMS
TOLMAR Pharmaceuticals, Inc. $15.2402/17/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 836494019 CMS
AbbVie Inc. $19.0902/16/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 795695763 CMS
Medtronic, Inc. $15.5902/16/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 815597795 CMS
Novo Nordisk Inc $2,023.0002/15/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 810839145 CMS
Lilly USA, LLC $800.0002/12/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 819151521 CMS
Novo Nordisk Inc $24.4202/12/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 811223181 CMS
AbbVie Inc. $1,350.0002/11/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 795695757 CMS
Alexion Pharmaceuticals, Inc. $775.0002/09/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783122631 CMS
Novo Nordisk Inc $5.6902/08/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 810693535 CMS
Medtronic, Inc. $16.1402/04/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 815578653 CMS
VistaPharm, Inc. $19.2402/03/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 837695095 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $165,537.17 304
PY2020 $68,558.19 149
PY2021 $92,637.89 208
PY2022 $153,823.86 314
PY2023 $97,245.98 229
PY2024 $95,948.65 163
PY2025 $131,012.22 209

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $441,048.05 62
PY2024 Principal investigator $698,877.58 643
PY2023 Principal investigator $468,256.83 448
PY2022 Recipient $3,200.00 1
PY2022 Principal investigator $292,265.21 229
PY2021 Recipient $1,635.09 4
PY2021 Principal investigator $238,681.85 69
PY2020 Recipient $7,054.41 5
PY2020 Principal investigator $419,100.59 92
PY2019 Recipient $16,285.90 3
PY2019 Principal investigator $421,262.47 117

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

62 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Merck Sharp & Dohme LLC $449.60 12/31/2025 Covered Recipient Teaching Hospital
Sutter Medical Center - Sacramento
A Phase III, Multicenter, Double-Blind, Randomized, Placebo-Controlled Clinical Trial to Evaluate the Safety and Efficacy of Sitagliptin in Pediatric Patients with Type 2 Diabetes Mellitus with Inadequate Glycemic Control No dispute reported 06/30/2026 1232917995
Principal investigator 1 BioMarin Pharmaceutical Inc. $3,183.30 12/22/2025 Covered Recipient Teaching Hospital
Sutter Medical Center - Sacramento
BMN 111-210 No dispute reported 06/30/2026 1248578840
Principal investigator 1 BioMarin Pharmaceutical Inc. $8,017.65 12/22/2025 Covered Recipient Teaching Hospital
Sutter Medical Center - Sacramento
BMN 111-210 No dispute reported 06/30/2026 1248578842
Principal investigator 1 Novo Nordisk AS $600.00 12/22/2025 Non-covered Recipient Entity
CENTER OF EXCELLENCE IN DIABETES AND ENDOCRINOLOGY
NN8640-4469 No dispute reported 06/30/2026 1213743307
Principal investigator 1 Novo Nordisk AS $4,138.92 12/22/2025 Non-covered Recipient Entity
CENTER OF EXCELLENCE IN DIABETES AND ENDOCRINOLOGY
NN8640-4469 No dispute reported 06/30/2026 1213772480
Principal investigator 1 Novo Nordisk AS $75.00 12/22/2025 Non-covered Recipient Entity
CENTER OF EXCELLENCE IN DIABETES AND ENDOCRINOLOGY
NN8640-4469 No dispute reported 06/30/2026 1213790867
Principal investigator 1 Novo Nordisk AS $200.00 12/22/2025 Non-covered Recipient Entity
CENTER OF EXCELLENCE IN DIABETES AND ENDOCRINOLOGY
NN8640-4469 No dispute reported 06/30/2026 1213808834
Principal investigator 1 Novo Nordisk AS $890.00 12/22/2025 Non-covered Recipient Entity
CENTER OF EXCELLENCE IN DIABETES AND ENDOCRINOLOGY
NN8640-4469 No dispute reported 06/30/2026 1213822462
Principal investigator 1 Novo Nordisk AS $25.00 12/22/2025 Non-covered Recipient Entity
CENTER OF EXCELLENCE IN DIABETES AND ENDOCRINOLOGY
NN8640-4469 No dispute reported 06/30/2026 1213825212
Principal investigator 1 Novo Nordisk AS $2,160.00 11/20/2025 Non-covered Recipient Entity
CENTER OF EXCELLENCE IN DIABETES AND ENDOCRINOLOGY
NN8640-4469 No dispute reported 06/30/2026 1213819467
Principal investigator 1 Novo Nordisk AS $800.00 10/29/2025 Non-covered Recipient Entity
CENTER OF EXCELLENCE IN DIABETES AND ENDOCRINOLOGY
NN8640-4469 No dispute reported 06/30/2026 1213709674
Principal investigator 1 Novo Nordisk AS $100.00 10/29/2025 Non-covered Recipient Entity
CENTER OF EXCELLENCE IN DIABETES AND ENDOCRINOLOGY
NN8640-4469 No dispute reported 06/30/2026 1213775783
Principal investigator 1 Novo Nordisk AS $1,620.00 10/29/2025 Non-covered Recipient Entity
CENTER OF EXCELLENCE IN DIABETES AND ENDOCRINOLOGY
NN8640-4469 No dispute reported 06/30/2026 1213777182
Principal investigator 1 Novo Nordisk AS $890.00 10/29/2025 Non-covered Recipient Entity
CENTER OF EXCELLENCE IN DIABETES AND ENDOCRINOLOGY
NN8640-4469 No dispute reported 06/30/2026 1213828173
Principal investigator 1 Ascendis Pharma Endocrinology Inc $2,046.80 10/09/2025 Covered Recipient Teaching Hospital
Sutter Medical Center - Sacramento
SkybriGHt No dispute reported 06/30/2026 1233997163
Principal investigator 1 Ascendis Pharma Endocrinology Inc $1,914.20 10/09/2025 Covered Recipient Teaching Hospital
Sutter Medical Center - Sacramento
SkyPASS No dispute reported 06/30/2026 1233997167
Principal investigator 1 BioMarin Pharmaceutical Inc. $3,999.00 10/01/2025 Covered Recipient Teaching Hospital
Sutter Davis Hospital
A Phase 2, Randomized, Controlled, Multicenter Study of Vosoritide in Children With Idiopathic Short Stature No dispute reported 06/30/2026 1248578826
Principal investigator 1 Eli Lilly and Company $1,743.00 09/29/2025 Covered Recipient Teaching Hospital
SUTTER MEDICAL CENTER - SACRAMENTO
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 3 STUDY WITH AN OPEN-LABEL EXTENSION ASSESSING THE EFFICACY, SAFETY, AND PHARMACOKINETICS PHARMACODYNAMICS OF TIRZEPATIDE IN PEDIATRIC AND ADOLESCENT PARTICIPANTS WITH TYPE 2 DIABETES MELLITUS INADEQUATELY CONTROLLED WITH METFORMIN, OR BASAL INSULIN, OR BOTH No dispute reported 06/30/2026 1187874751
Principal investigator 1 Eli Lilly and Company $95,164.00 09/23/2025 Covered Recipient Teaching Hospital
SUTTER MEDICAL CENTER - SACRAMENTO
EFFICACY AND SAFETY OF TIRZEPATIDE ONCE WEEKLY VERSUS PLACEBO FOR THE TREATMENT OF OBESITY AND WEIGHT-RELATED COMORBIDITIES IN ADOLESCENTS: A RANDOMIZED, DOUBLE-BLIND, PLACEBO- CONTROLLED TRIAL (SURMOUNT-ADOLESCENTS-2) No dispute reported 06/30/2026 1187875089
Principal investigator 1 BioMarin Pharmaceutical Inc. $1,500.00 09/19/2025 Covered Recipient Teaching Hospital
Sutter Medical Center - Sacramento
BMN 111-210 No dispute reported 06/30/2026 1248578838
Principal investigator 1 Novo Nordisk AS $400.00 09/19/2025 Non-covered Recipient Entity
CENTER OF EXCELLENCE IN DIABETES AND ENDOCRINOLOGY
NN8640-4469 No dispute reported 06/30/2026 1213719863
Principal investigator 1 Novo Nordisk AS $25.00 09/19/2025 Non-covered Recipient Entity
CENTER OF EXCELLENCE IN DIABETES AND ENDOCRINOLOGY
NN8640-4469 No dispute reported 06/30/2026 1213835382
Principal investigator 1 Dexcom, Inc. $3,862.00 09/03/2025 Non-covered Recipient Entity
Center of Excellence in Diabetes and Endocrinology
POST APPROVAL STUDY FOR NON-ADJUNCTIVE USE OF DEXCOM G5 AND G6 CGM SYSTEM FOR DIABETES MANAGEMENT (COACH) No dispute reported 06/30/2026 1250961568
Principal investigator 1 Ascendis Pharma Endocrinology Inc $3,070.20 08/26/2025 Covered Recipient Teaching Hospital
Sutter Medical Center - Sacramento
SkybriGHt No dispute reported 06/30/2026 1233996701
Principal investigator 1 Ascendis Pharma Endocrinology Inc $2,871.30 08/26/2025 Covered Recipient Teaching Hospital
Sutter Medical Center - Sacramento
SkyPASS No dispute reported 06/30/2026 1233996703
Principal investigator 1 BioMarin Pharmaceutical Inc. $13,734.00 08/25/2025 Covered Recipient Teaching Hospital
Sutter Medical Center - Sacramento
BMN 111-903 No dispute reported 06/30/2026 1248578834
Principal investigator 1 BioMarin Pharmaceutical Inc. $4,550.85 08/25/2025 Covered Recipient Teaching Hospital
Sutter Medical Center - Sacramento
BMN 111-210 No dispute reported 06/30/2026 1248578836
Principal investigator 1 Novo Nordisk AS $1,967.04 08/22/2025 Non-covered Recipient Entity
CENTER OF EXCELLENCE IN DIABETES AND ENDOCRINOLOGY
NN8640-4467 No dispute reported 06/30/2026 1213702318
Principal investigator 1 Novo Nordisk AS $810.00 08/22/2025 Non-covered Recipient Entity
CENTER OF EXCELLENCE IN DIABETES AND ENDOCRINOLOGY
NN8640-4469 No dispute reported 06/30/2026 1213773411
Principal investigator 1 Novo Nordisk AS $2,500.00 08/04/2025 Non-covered Recipient Entity
CENTER OF EXCELLENCE IN DIABETES AND ENDOCRINOLOGY
NN8640-4469 No dispute reported 06/30/2026 1213842524
Principal investigator 1 Ascendis Pharma Endocrinology Inc $1,023.40 07/31/2025 Covered Recipient Teaching Hospital
Sutter Medical Center - Sacramento
SkybriGHt No dispute reported 06/30/2026 1233996613
Principal investigator 1 Ascendis Pharma Endocrinology Inc $957.10 07/31/2025 Covered Recipient Teaching Hospital
Sutter Medical Center - Sacramento
SkyPASS No dispute reported 06/30/2026 1233996617
Principal investigator 1 BioMarin Pharmaceutical Inc. $3,238.65 07/25/2025 Covered Recipient Teaching Hospital
Sutter Medical Center - Sacramento
BMN 111-210 No dispute reported 06/30/2026 1248578832
Principal investigator 1 Dexcom, Inc. $13,476.00 07/22/2025 Non-covered Recipient Entity
Center of Excellence in Diabetes and Endocrinology
POST APPROVAL STUDY FOR NON-ADJUNCTIVE USE OF DEXCOM G5 AND G6 CGM SYSTEM FOR DIABETES MANAGEMENT (COACH) No dispute reported 06/30/2026 1250961564
Principal investigator 1 Novo Nordisk AS $2,160.00 07/16/2025 Non-covered Recipient Entity
CENTER OF EXCELLENCE IN DIABETES AND ENDOCRINOLOGY
NN8640-4469 No dispute reported 06/30/2026 1213764365
Principal investigator 1 Dexcom, Inc. $7,118.00 07/08/2025 Non-covered Recipient Entity
Center of Excellence in Diabetes and Endocrinology
POST APPROVAL STUDY FOR NON-ADJUNCTIVE USE OF DEXCOM G5 AND G6 CGM SYSTEM FOR DIABETES MANAGEMENT (COACH) No dispute reported 06/30/2026 1250961566
Principal investigator 1 Novo Nordisk AS $2,160.00 06/30/2025 Non-covered Recipient Entity
CENTER OF EXCELLENCE IN DIABETES AND ENDOCRINOLOGY
NN8640-4469 No dispute reported 06/30/2026 1213794822
Principal investigator 1 BioMarin Pharmaceutical Inc. $10,146.60 06/25/2025 Covered Recipient Teaching Hospital
Sutter Medical Center - Sacramento
BMN 111-210 No dispute reported 06/30/2026 1248578830
Principal investigator 1 Dexcom, Inc. $6,779.00 06/10/2025 Non-covered Recipient Entity
Center of Excellence in Diabetes and Endocrinology
POST APPROVAL STUDY FOR NON-ADJUNCTIVE USE OF DEXCOM G5 AND G6 CGM SYSTEM FOR DIABETES MANAGEMENT (COACH) No dispute reported 06/30/2026 1250961574
Principal investigator 1 Novo Nordisk AS $1,800.00 05/21/2025 Non-covered Recipient Entity
CENTER OF EXCELLENCE IN DIABETES AND ENDOCRINOLOGY
NN8640-4469 No dispute reported 06/30/2026 1213703182
Principal investigator 1 Novo Nordisk AS $5,902.87 05/21/2025 Non-covered Recipient Entity
CENTER OF EXCELLENCE IN DIABETES AND ENDOCRINOLOGY
NN8640-4263 No dispute reported 06/30/2026 1213723030
Principal investigator 1 Dexcom, Inc. $38,012.00 05/13/2025 Non-covered Recipient Entity
Center of Excellence in Diabetes and Endocrinology
POST APPROVAL STUDY FOR NON-ADJUNCTIVE USE OF DEXCOM G5 AND G6 CGM SYSTEM FOR DIABETES MANAGEMENT (COACH) No dispute reported 06/30/2026 1250961572
Principal investigator 1 BioMarin Pharmaceutical Inc. $5,073.30 05/02/2025 Covered Recipient Teaching Hospital
Sutter Medical Center - Sacramento
BMN 111-210 No dispute reported 06/30/2026 1248578828
Principal investigator 1 Dexcom, Inc. $9,126.00 04/28/2025 Non-covered Recipient Entity
Center of Excellence in Diabetes and Endocrinology
POST APPROVAL STUDY FOR NON-ADJUNCTIVE USE OF DEXCOM G5 AND G6 CGM SYSTEM FOR DIABETES MANAGEMENT (COACH) No dispute reported 06/30/2026 1250961570
Principal investigator 1 Dexcom, Inc. $18,490.00 04/28/2025 Non-covered Recipient Entity
Center of Excellence in Diabetes and Endocrinology
POST APPROVAL STUDY FOR NON-ADJUNCTIVE USE OF DEXCOM G5 AND G6 CGM SYSTEM FOR DIABETES MANAGEMENT (COACH) No dispute reported 06/30/2026 1250961576
Principal investigator 1 Dexcom, Inc. $32,287.00 04/28/2025 Non-covered Recipient Entity
Center of Excellence in Diabetes and Endocrinology
POST APPROVAL STUDY FOR NON-ADJUNCTIVE USE OF DEXCOM G5 AND G6 CGM SYSTEM FOR DIABETES MANAGEMENT (COACH) No dispute reported 06/30/2026 1250961578
Principal investigator 1 Novo Nordisk AS $150.00 04/21/2025 Non-covered Recipient Entity
CENTER OF EXCELLENCE IN DIABETES AND ENDOCRINOLOGY
NN8640-4469 No dispute reported 06/30/2026 1213718096
Principal investigator 1 Novo Nordisk AS $2,315.00 04/21/2025 Non-covered Recipient Entity
CENTER OF EXCELLENCE IN DIABETES AND ENDOCRINOLOGY
NN8640-4469 No dispute reported 06/30/2026 1213727836
Principal investigator 1 Novo Nordisk AS $810.00 04/21/2025 Non-covered Recipient Entity
CENTER OF EXCELLENCE IN DIABETES AND ENDOCRINOLOGY
NN8640-4469 No dispute reported 06/30/2026 1213809309
Principal investigator 1 PFIZER INC. $1,500.00 04/02/2025 Covered Recipient Teaching Hospital
Sutter Davis Hospital
PFIZER REGISTRY OF OUTCOMES IN GROWTH HORMONE RESEARCH PROGRES A MULTI COUNTRY NONINTERVENTIONAL PROSPECTIVE COHORT STUDY AMONG PATIENTS WITH HUMAN GROWTH HORMONE HGH TREATMENTS UNDER ROUTINE CLINICAL CARE No dispute reported 06/30/2026 1228851336
Principal investigator 1 Novo Nordisk AS $810.00 03/28/2025 Non-covered Recipient Entity
CENTER OF EXCELLENCE IN DIABETES AND ENDOCRINOLOGY
NN8640-4469 No dispute reported 06/30/2026 1213776664
Principal investigator 1 Dexcom, Inc. $303.00 03/11/2025 Non-covered Recipient Entity
Center of Excellence in Diabetes and Endocrinology
POST APPROVAL STUDY FOR NON-ADJUNCTIVE USE OF DEXCOM G5 AND G6 CGM SYSTEM FOR DIABETES MANAGEMENT (COACH) No dispute reported 06/30/2026 1250961550
Principal investigator 1 Dexcom, Inc. $15,556.75 03/11/2025 Non-covered Recipient Entity
Center of Excellence in Diabetes and Endocrinology
POST APPROVAL STUDY FOR NON-ADJUNCTIVE USE OF DEXCOM G5 AND G6 CGM SYSTEM FOR DIABETES MANAGEMENT (COACH) No dispute reported 06/30/2026 1250961558
Principal investigator 1 Dexcom, Inc. $6,183.75 03/11/2025 Non-covered Recipient Entity
Center of Excellence in Diabetes and Endocrinology
POST APPROVAL STUDY FOR NON-ADJUNCTIVE USE OF DEXCOM G5 AND G6 CGM SYSTEM FOR DIABETES MANAGEMENT (COACH) No dispute reported 06/30/2026 1250961562
Principal investigator 1 Novo Nordisk AS $2,580.00 02/21/2025 Non-covered Recipient Entity
CENTER OF EXCELLENCE IN DIABETES AND ENDOCRINOLOGY
NN8640-4469 No dispute reported 06/30/2026 1213740792
Principal investigator 1 Novo Nordisk AS $75.00 02/21/2025 Non-covered Recipient Entity
CENTER OF EXCELLENCE IN DIABETES AND ENDOCRINOLOGY
NN8640-4469 No dispute reported 06/30/2026 1213773637
Principal investigator 1 Novo Nordisk AS $2,610.00 02/21/2025 Non-covered Recipient Entity
CENTER OF EXCELLENCE IN DIABETES AND ENDOCRINOLOGY
NN8640-4469 No dispute reported 06/30/2026 1213800863
Principal investigator 1 Eli Lilly and Company $2,654.52 01/31/2025 Non-covered Recipient Entity
CENTER OF EXCELLENCE IN DIABETES
EFFICACY AND SAFETY OF TIRZEPATIDE ONCE WEEKLY VERSUS PLACEBO FOR THE TREATMENT OF OBESITY AND WEIGHT-RELATED COMORBIDITIES IN ADOLESCENTS: A RANDOMIZED, DOUBLE-BLIND, PLACEBO- CONTROLLED TRIAL (SURMOUNT-ADOLESCENTS-2) No dispute reported 06/30/2026 1187879293
Principal investigator 1 Dexcom, Inc. $15,490.00 01/28/2025 Non-covered Recipient Entity
Center of Excellence in Diabetes and Endocrinology
POST APPROVAL STUDY FOR NON-ADJUNCTIVE USE OF DEXCOM G5 AND G6 CGM SYSTEM FOR DIABETES MANAGEMENT (COACH) No dispute reported 06/30/2026 1250961552
Principal investigator 1 Dexcom, Inc. $6,476.00 01/28/2025 Non-covered Recipient Entity
Center of Excellence in Diabetes and Endocrinology
POST APPROVAL STUDY FOR NON-ADJUNCTIVE USE OF DEXCOM G5 AND G6 CGM SYSTEM FOR DIABETES MANAGEMENT (COACH) No dispute reported 06/30/2026 1250961554
Principal investigator 1 Dexcom, Inc. $43,958.00 01/28/2025 Non-covered Recipient Entity
Center of Excellence in Diabetes and Endocrinology
POST APPROVAL STUDY FOR NON-ADJUNCTIVE USE OF DEXCOM G5 AND G6 CGM SYSTEM FOR DIABETES MANAGEMENT (COACH) No dispute reported 06/30/2026 1250961556
Principal investigator 1 Dexcom, Inc. $18,519.25 01/28/2025 Non-covered Recipient Entity
Center of Excellence in Diabetes and Endocrinology
POST APPROVAL STUDY FOR NON-ADJUNCTIVE USE OF DEXCOM G5 AND G6 CGM SYSTEM FOR DIABETES MANAGEMENT (COACH) No dispute reported 06/30/2026 1250961560